- Nonspecific Interstitial Pneumonitis after Bortezomib and Thalidomide Treatment in a Multiple Myeloma Patient
-
Kang W, Kim JS, Cho SH, Kim SK, Chang J, Park MS
- KMID: 1074999
- Yonsei Med J.
- 2010 May;51(3):448-450.
- doi: 10.3349/ymj.2010.51.3.448
Bortezomib, an inhibitor of 26S proteosome, is recently approved treatment option for multiple myeloma. Thalidomide, a drug with immunomodulating and antiangiogenic effects, has also shown promise as an effective treatment... -
- CITED
-
- Close
- SHARE
-
- Close
